Pharmacology, Toxicology and Pharmaceutical Science
Acute Lung Injury
8%
Adult Respiratory Distress Syndrome
8%
Chronic Lung Disease
16%
Chronic Obstructive Lung Disease
8%
Combination Therapy
8%
Diphtheria Toxin
8%
Disease
100%
Disease Exacerbation
8%
EC50
8%
Fibrosing Alveolitis
8%
Fusion Protein
16%
Injury
16%
Lung Disease
100%
Lung Fibrosis
8%
Mouse
50%
Prevalence
8%
Respiratory Tract Disease
8%
Surfactant Protein A
91%
Surfactant Protein C
8%
Therapeutic Effect
8%
Medicine and Dentistry
Acute Lung Injury
5%
Acute Respiratory Distress Syndrome
5%
Aeroallergen
5%
Alveolar Type II Cells
100%
Cell Membrane
5%
Cell Therapy
10%
Childbirth
5%
Chronic Lung Disease
10%
Chronic Obstructive Pulmonary Disease
5%
Combination Therapy
5%
Diphtheria Toxin
5%
Disease Exacerbation
5%
Diseases
100%
Ex Vivo
5%
Fusion Protein
10%
Homeostasis
5%
Idiopathic Pulmonary Fibrosis
5%
In Vitro
10%
Injury
10%
Intratracheal Drug Administration
5%
Lung Epithelium
5%
Lung Structure
5%
Lung Transplantation
5%
Population
5%
Prevalence
5%
Programmed Cell Death
10%
Pulmonary Fibrosis
5%
Respiratory Disease
5%
Silo-Filler's Disease
60%
Surfactant Protein A
55%
Surfactant Protein C
5%
Therapy Effect
5%
Veterans Affairs
5%